ClinicalTrials.gg
CompletedNCT04821167LapUDTUpdated Mar 29, 2021

Safety and Efficiency of Laparoscopic Management of Intra-canalicular (Emergent) Testis

An interventional study of laparoscopic orchiopexy for intra-canalicular testis in Testes Undescend, sponsored by dr. Muhammad Abdelhafez Mahmoud, MD. Completed at 1 site in Egypt. Open to male participants aged 8 Months to 48 Months. Per ClinicalTrials.gov, last updated 2021-03-29.

Sponsored by dr. Muhammad Abdelhafez Mahmoud, MD · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled Jan 2019, registered Mar 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Not applicable
Ages
8 Months to 48 Months
Sex
Male
01

Study summary

Undescended testes (UDTs) are a relatively common finding in pediatrics with prevalence about 1-2% in newborns. Upon discovering a non-intrascrotal testis, it is important to determine whether the testis is palpable or non-palpable (1). A canalicular or 'emergent' testis may be impalpable initially and may be appear when it is 'milked' out of the inguinal canal (where it is concealed from detection) indicating that 15 to 40% of cryptorchidism are viable peeping/canalicular testis.

The laparoscopic approach for treating canalicular undescended testes offers many advantages over open inguinal orchiopexy. The laparoscopic technique maintains the integrity of the inguinal canal anatomy and eliminating the need to divide the epigastric vessels during dissection. The ability to dissect the testicular vessels at a higher extent would increase the vessel length available to lower the testis without strain.

  • This is a prospective study will be conducted at Department of Pediatric Surgery, MCH hospital, Bisha, Saudia Arabia and Pediatric surgery Department , Al-Azhar University hospitals, Cairo, Egypt, from January 2019 to October 2020 to evaluate the safety and efficiency of laparoscopic orchiopexy of intracanalicular testis.
  • Patients' age and laterality will be reported. Evaluation will be done for the operative difficulties, intraoperative complications, operative time and early postoperative complications.

Testicular site, size and vascularity will be evaluated by ultrasonography at 6th month post operatively. Also, cosmetic results will be evaluated by obtaining the parent's questioners at post-operative OPD clinic visits.

  • Laparoscopic orchiopexy for management of inguinal canalicular undescended testes is a safe, effective, and less invasive, without disturbance of inguinal canal anatomy, with better cosmetic results.
Read the detailed description

Aim of the study:

Herein, the study aims to evaluate the laparoscopic procedure for management of canalicular testis regarding operative safety, efficacy and post-operative outcomes.

Brief review of literature:

  • Different management modalities for intra-canalicular (emergent) testes in male children (open surgery, Laparoscopy).
  • Advantages of laparoscopic orchiopexy for intra-canalicular (emergent) testes.

Patients and Methods:

This is a prospective study, will be conducted out at pediatric surgery tertiary centers (Maternity \& Children's Hospital in Bisha, KSA and Al-Azhar University hospitals in Cairo, Egypt) on pediatric patients presenting at the pediatric surgery OPD clinic by intra-canalicular (emergent/peeping) testes in the period from January 2019 to October 2020. Enrolled patients will be managed by laparoscopic orchiopexy. All patients enrolled in the study will give a written informed consent. The study will be approved by the Institutional Review Board and ethics committee of the hospitals. The main objective is to assess safety and efficacy of laparoscopic orchiopexy for intra-canalicular (emergent/peeping) testes in male patients.

Institutes of the study:

A multicenter study at Pediatric Surgery Departments, Maternity \& Children's hospital in Bisha, KSA and Al-Azhar University hospitals in Cairo.

Number of cases: Sixty two male children. Time frame: period of 1.10 years.

Ethical Consideration:

The protocol will be discussed and approved for clinical study by the Ethical Research Committee at MCH at Bisha, KSA, and other participating hospitals. The procedures and the aim of the study will be clearly explained to the patient and the family. A written informed consent will be obtained before enrollment of the patients into the study. The family refusal to give consent for laparoscopic management is respected but does not deprive the patient from getting open orchiopexy.

Preoperative preparation:

Proper examination done for patients using flat and frog leg position with gentile squeezing of testis down, proved by preoperative inguinoscrotal ultrasonography.

Follow-up:

Patients will be reviewed at the OPD clinic. Patients who could not attend the clinic will be contacted by phone. Postoperative Doppler ultrasonography will be done to assess testicular size and vascularity. Questionnaire will be obtained from the parents to assess their cosmetic satisfaction.

Statistical analysis:

It will be performed with IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp. Data will be presented as mean, standard deviation, number \& percentage, using Chi-squared test (X2) for qualitative data. The significance level will be set at P > 0.05.

  • Discussion will focus on laparoscopic management of intra-canalicular (emergent) testes. The results obtained from this study will be compared with each other and with that reported in the literature. The discussion will focus on operative details, operative time, results, \& complications.

It will compare results of this study with the results of others. Discussion will determine the most accurate management modality for intra-canalicular (emergent) testes in male children which offers the best outcome and least morbidity.

02

Conditions studied

  • Testes Undescend

Browse trials for

Keywords

  • Laparoscopic,
  • orchiopexy,
  • intracanalicuar testes,
  • peeping testes
03

In context

Cryptorchidism

40 studies on the registry are indexed under Cryptorchidism; 14 are open to participants now.

This study's enrollment of 62 is below the median of 70 across 26 interventional studies indexed under Cryptorchidism.

Browse Cryptorchidism studies →

Lead sponsor

dr. Muhammad Abdelhafez Mahmoud, MD is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Months to 48 Months
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All children diagnosed as intra-canalicular (emergent/ peeping) testes

Exclusion criteria

Exclusion Criteria:

  • Patients above 14 years of age,
  • with retractile testes,
  • with retractile testes that were distal to the external ring and
  • with nonpalpable testes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
62 participants (actual)

Study arms

  • Other
    Laparoscopic orchiopexy for intra-canalicular (emergent or peeping) testis

    This is a prospective study conducted on male children with intermittent palpable (peeping) UDT to evaluate the safety and efficiency of laparoscopic orchiopexy of intra-canalicular (emergent or peeping) testis.

    Procedure: laparoscopic orchiopexy for intra-canalicular testis

Interventions

  • Procedurelaparoscopic orchiopexy for intra-canalicular testis

    laparoscopic orchiolysis of abnormal fibrous attachments and then lap assisted transcrotal fixation of the testis in subdartos pouch for intra-canalicular testis

06

What researchers measure

Primary outcomes

  1. Patients' age (in months)

    Patients' age

    Time frame: 2 years

  2. Patients' weight (in kilograms)

    Patients' weight

    Time frame: 2 years

  3. Side of affected testis (number of cases)

    The side of the affected testis

    Time frame: 2 years

Secondary outcomes

  1. Operative time (in minutes)

    Operative time

    Time frame: 1 day (day of surgery)

  2. Testicular size (in cubic milliliters)

    Testicular size measurement by ultrasonography

    Time frame: 2 years

  3. Testicular site (in centimeters)

    Testicular distance from the mid-scrotum point to evaluate that it remained in the scrotum or re-ascended

    Time frame: 2 years

  4. Parents' satisfaction (percent of each satisfaction grade)

    Parents' satisfaction questionnaire

    Time frame: 2 years

  5. Period of follow-up (in months)

    Follow-up period

    Time frame: 2 years

07

Study locations

1 site
  • Mohammad Alsayed Daboos
    Cairo, 11651, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — Data are available for other researchers including methodology, figures, tables, results, and philosophy of discussion and the value this study add to the literature

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: October 2020 till indefinitely

Access criteria: after the article became accepted and available online.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 29, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04821167
Lead sponsor
dr. Muhammad Abdelhafez Mahmoud, MD
Responsible party
dr. Muhammad Abdelhafez Mahmoud, MD (Lecturer of pediatric surgery, Al-Azhar Faculty of Medicine, Al-Azhar University) — Sponsor-investigator
First posted
Mar 29, 2021
Start date
Jan 1, 2019
Primary completion
Apr 20, 2020
Completion
Oct 31, 2020
Last update
Mar 29, 2021

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion